All companies
Cencora logo
HealthcareCOR

Cencora (COR) Financial Forecast Calculator

Interactive 5-year forecast and DCF for Cencora. Adjust revenue growth, gross margin, capex intensity, WACC, and terminal growth - see revenue, free cash flow, and enterprise value update in real time. Seeded from Cencora’s most recent SEC filings.

Revenue FY30
$420.70B
from $262.17B
FCF FY30
$11.57B
Margin 2.7%
Enterprise value
$157.13B
0.6× LTM revenue
Equity value
$156.13B
Net debt $999.9M
Revenue & free cash flow - history and 5-year forecast
Line (area)
Bars
Historicals from SEC EDGAR (grey). Forecast years (color) update live as you move the sliders.

Assumptions

Revenue growth (annual)
9.9%
-10.0%baseline 9.9%40.0%
Gross margin
5.0%
5.0%baseline 5.0%90.0%
Capex % of revenue
0.2%
0.0%baseline 0.2%30.0%
WACC (discount rate)
9.00%
4.0%baseline 9.0%18.0%
Terminal growth
2.50%
0.0%baseline 2.5%5.0%

Need this as an Excel model?

Keep iterating on the Cencora forecast in Excel. The downloadable sample has every assumption you see here plus a fully integrated income statement, balance sheet, cash flow, and debt schedule - five years of SEC historicals and live formulas in a fully editable workbook.

income_statement.xlsx
Income statement, brown brand palette
income_statement.xlsx
Income statement, green brand palette
income_statement.xlsx
Income statement, red brand palette

Frequently asked

What does Cencora do as a company?+

Cencora, formerly AmerisourceBergen, is one of the largest global pharmaceutical sourcing and distribution services companies. It provides drug distribution and related services designed to reduce costs and improve patient outcomes, primarily operating in the U.S. and Europe.

What are the primary drivers of Cencora's revenue growth?+

Cencora's revenue growth is primarily driven by pharmaceutical volume trends, generic pricing dynamics, and strategic capital allocation. Its U.S. Healthcare Solutions segment contributes approximately 89% of its total revenue.

What is Cencora's typical capital expenditure as a percentage of revenue?+

Cencora operates with very low capital intensity, with capital expenditure typically ranging from 0.15% to 0.25% of revenue. The company has a planned $1 billion investment program through 2030 to expand U.S. distribution and cold chain capacity.

What is the purpose of the Cencora financial model?+

The Cencora financial model provides a comprehensive three-statement forecast and discounted cash flow (DCF) valuation. Its primary purpose is to help an equity analyst determine the intrinsic value of Cencora based on key industry and company-specific factors.

Can I download an Excel financial model for Cencora?+

Yes, a downloadable Excel financial model for Cencora is available. This model provides a detailed forecast horizon from FY2026 through FY2030 for financial analysis.

How does Cencora's working capital profile impact its business model?+

Cencora often operates with negative net working capital, which is a structural advantage in its asset-light, high-volume, low-margin distribution business. This profile allows the company to effectively use supplier payables to fund its inventory.

Have more financial modelling questions? Contact us

Go further

Build the financial model you need with Fina

Browse templates, examples, and downloadable Excel models for the analysis you are trying to build. If you can't find your model, ask Fina to build a model for your specific needs.

Start for free
Excel financial model spreadsheet preview showing Customer Rollforward
Fina interactive chat interface preview